Skip to main content
Logo
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
  • News article
  • 28 May 2019
  • European Medicines Agency
  • 1 min read

ICH E19 public consultation

A new ICH-E19 draft guideline on the optimisation of safety data collection in interventional clinical trials and non-interventional studies has been published by ICH for public consultation. The guideline objective is to provide internationally harmonised guidance on when it would be appropriate to use a selective approach to safety data collection in some late-stage pre-marketing or post-marketing studies, and how such approach would be implemented. Comments should be submitted by 29 September 2019 to the following email address: ichatema [dot] europa [dot] eu (ich[at]ema[dot]europa[dot]eu).

 

Related information:

» ICH E19 public consultation version 

» EMA public consultations 

Details

Publication date
28 May 2019
Author
European Medicines Agency